XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.1

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($)	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Investments at cost	$ 790,592,000	$ 766,774,000
Investments at fair value	689,553,000	697,891,000
Unrestricted Short Term Investments [Member]
Investments at cost	40,968,000	27,266,000
Investments at fair value	40,968,000	27,266,000
Restricted Short Term Investments [Member]
Investments at cost	3,463,000	3,338,000
Investments at fair value	3,463,000	3,338,000
Equity Securities [Member]
Investments at cost	37,988,000	35,942,000
Investments at fair value	13,686,000	26,198,000
Warrant [Member]
Investments at cost	16,120,000	15,956,000
Investments at fair value	18,603,000	18,277,000
U S Bank Money Market Deposit Account [Member] | Unrestricted Short Term Investments [Member]
Investments at cost	40,968,000	27,266,000
Investments at fair value	40,968,000	27,266,000
U S Bank Money Market Deposit Account [Member] | Restricted Short Term Investments [Member]
Investments at cost	3,463,000	3,338,000
Investments at fair value	3,463,000	3,338,000
Medical Device Sector [Member]
Investments at cost	220,360,000	213,564,000
Investments at fair value	192,105,000	205,634,000
Software Sector [Member]
Investments at cost	161,916,000	154,040,000
Investments at fair value	159,213,000	151,043,000
Biotechnology Sector [Member]
Investments at cost	138,360,000	118,221,000
Investments at fair value	116,174,000	97,562,000
Other Sustainability Sector [Member]
Investments at cost	65,329,000	66,151,000
Investments at fair value	64,109,000	66,079,000
Energy Efficiency [Member]
Investments at cost	9,824,000	9,818,000
Investments at fair value	9,713,000	9,712,000
Other Healthcare Sector [Member]
Investments at cost	39,552,000	39,533,000
Investments at fair value	40,166,000	40,144,000
Networking Sector [Member]
Investments at cost	10,076,000	10,070,000
Investments at fair value	9,826,000	9,827,000
Diagnostics Sector [Member]
Investments at cost	17,252,000	16,704,000
Investments at fair value	14,661,000	13,701,000
Communications Sector [Member]
Investments at cost	518,000	11,711,000
Investments at fair value	3,547,000	14,763,000
Investment, Unaffiliated Issuer [Member]
Investments at cost	715,151,000	694,503,000
Investments at fair value	666,377,000	657,765,000
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member]
Investments at cost	9,699,000	9,653,000
Investments at fair value	5,776,000	8,277,000
Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	15,993,000	15,829,000
Investments at fair value	18,603,000	18,277,000
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	680,982,000	660,556,000
Investments at fair value	641,898,000	631,111,000
Investment, Unaffiliated Issuer [Member] | Other Investments [Member]
Investments at cost	8,477,000	8,465,000
Investments at fair value	100,000	100,000
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Common Stock [Member]
Investments at cost	250,000	250,000
Investments at fair value	$ 250,000	$ 250,000
Number of Shares (in shares)	1,162	1,162
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Common Stock [Member]
Investments at cost	$ 402,000	$ 356,000
Investments at fair value	$ 512,000	$ 356,000
Number of Shares (in shares)	37,017	32,831
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock [Member]
Investments at cost	$ 89,000	$ 89,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	2,688,971	2,688,971
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Preferred Stock [Member]
Investments at cost	$ 261,000	$ 261,000
Investments at fair value	$ 306,000	$ 306,000
Number of Shares (in shares)	1,810	1,810
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Common Stock [Member]
Investments at cost	$ 487,000	$ 487,000
Investments at fair value	$ 487,000	$ 487,000
Number of Shares (in shares)	8,123,877	8,123,877
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Preferred Stock [Member]
Investments at cost	$ 250,000	$ 250,000
Investments at fair value	$ 250,000	$ 250,000
Number of Shares (in shares)	1,059,636	1,059,636
Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Common Stock [Member]
Investments at cost	$ 2,000,000	$ 2,000,000
Investments at fair value	$ 1,700,000	$ 1,700,000
Number of Shares (in shares)	392,651	392,651
Investment, Unaffiliated Issuer [Member] | Cadrenal Therapeutics, Inc. [Member] | Common Stock [Member]
Investments at cost	$ 0	$ 0
Investments at fair value	$ 705,000	$ 580,000
Number of Shares (in shares)	40,000	40,000
Investment, Unaffiliated Issuer [Member] | PebblePost, Inc [Member] | Preferred Stock [Member]
Investments at cost	$ 73,000	$ 73,000
Investments at fair value	$ 73,000	$ 73,000
Number of Shares (in shares)	56,212	56,212
Investment, Unaffiliated Issuer [Member] | Caastle, Inc [Member] | Preferred Stock [Member]
Investments at cost	$ 2,681,000	$ 2,681,000
Investments at fair value	$ 0	$ 2,681,000
Number of Shares (in shares)	242,180	242,180
Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Common Stock [Member]
Investments at cost	$ 253,000	$ 253,000
Investments at fair value	$ 3,000	$ 3,000
Number of Shares (in shares)	87,082	87,082
Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Common Stock [Member]
Investments at cost	$ 9,000	$ 9,000
Investments at fair value	$ 0	$ 83,000
Number of Shares (in shares)	82,974	82,974
Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Common Stock [Member]
Investments at cost	$ 111,000	$ 111,000
Investments at fair value	$ 4,000	$ 5,000
Number of Shares (in shares)	5,205	5,205
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Preferred Stock [Member]
Investments at cost	$ 2,800,000	$ 2,800,000
Investments at fair value	$ 1,281,000	$ 1,281,000
Number of Shares (in shares)	280,000	280,000
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock [Member]
Investments at cost	$ 4,000	$ 4,000
Investments at fair value	$ 179,000	$ 193,000
Number of Shares (in shares)	66,127	66,127
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock 2 [Member]
Investments at cost	$ 29,000	$ 29,000
Investments at fair value	$ 26,000	$ 29,000
Number of Shares (in shares)	9,381	9,381
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Debt Securities [Member]
Investments at cost		$ 263,280,000
Investments at fair value		261,520,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 147,000	147,000
Investments at fair value	$ 972,000	$ 1,573,000
Number of Shares (in shares)	89,903	89,903
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	10.25%	10.25%
Margin	2.75%	2.75%
Floor	9.25%	9.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Mar. 01, 2029	Mar. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,823,000	4,820,000
Investments at fair value	$ 4,823,000	$ 4,820,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	10.25%	10.25%
Margin	2.75%	2.75%
Floor	9.25%	9.25%
Ceiling	0.00%	0.00%
ETP		4.00%
Maturity Date	Mar. 01, 2029	Mar. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,944,000	4,941,000
Investments at fair value	$ 4,944,000	$ 4,941,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	10.25%	10.25%
Margin	2.75%	2.75%
Floor	9.25%	9.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Mar. 01, 2029	Mar. 01, 2029
Principal Amount	$ 4,000,000	$ 4,000,000
Investments at cost	3,955,000	3,952,000
Investments at fair value	3,955,000	$ 3,952,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		11.50%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 5,000,000
Investments at cost		4,785,000
Investments at fair value		4,785,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	152,000	152,000
Investments at fair value	$ 76,000	$ 78,000
Number of Shares (in shares)	93,336	93,336
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		11.50%
Ceiling		0.00%
ETP	4.00%	5.00%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 2,500,000
Investments at cost		2,468,000
Investments at fair value		$ 2,468,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate		11.50%
Margin		3.50%
Floor		11.50%
Ceiling		0.00%
ETP		5.00%
Maturity Date		Sep. 01, 2027
Principal Amount		$ 2,500,000
Investments at cost		2,468,000
Investments at fair value		$ 2,468,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 15,000,000	$ 15,000,000
Investments at cost	14,752,000	14,735,000
Investments at fair value	$ 14,752,000	$ 14,735,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 10,000,000	$ 10,000,000
Investments at cost	9,834,000	9,823,000
Investments at fair value	$ 9,834,000	$ 9,823,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,916,000	4,912,000
Investments at fair value	$ 4,916,000	$ 4,912,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,458,000	2,456,000
Investments at fair value	$ 2,458,000	$ 2,456,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,702,000	3,699,000
Investments at fair value	$ 3,702,000	$ 3,699,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,702,000	3,699,000
Investments at fair value	3,702,000	3,699,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	256,000	256,000
Investments at fair value	$ 29,000	$ 102,000
Number of Shares (in shares)	9,313,541	9,313,541
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.32%	12.32%
Margin	4.82%	4.82%
Floor	9.25%	9.25%
Ceiling	0.00%	0.00%
ETP	10.36%	10.36%
Maturity Date	Jul. 01, 2025	Jul. 01, 2025
Principal Amount	$ 2,897,000	$ 3,187,000
Investments at cost	2,888,000	3,168,000
Investments at fair value	$ 2,888,000	$ 3,168,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.32%	12.32%
Margin	4.82%	4.82%
Floor	9.25%	9.25%
Ceiling	0.00%	0.00%
ETP	10.36%	10.36%
Maturity Date	Jul. 01, 2025	Jul. 01, 2025
Principal Amount	$ 2,897,000	$ 3,187,000
Investments at cost	2,888,000	3,168,000
Investments at fair value	$ 2,888,000	$ 3,168,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	10.75%	10.75%
Margin	3.25%	3.25%
Floor	10.75%	10.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2030	Jan. 01, 2030
Principal Amount	$ 10,000,000	$ 10,000,000
Investments at cost	9,825,000	9,818,000
Investments at fair value	$ 9,825,000	$ 9,818,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	10.75%	10.75%
Margin	3.25%	3.25%
Floor	10.75%	10.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2030	Jan. 01, 2030
Principal Amount	$ 10,000,000	$ 10,000,000
Investments at cost	9,852,000	9,845,000
Investments at fair value	$ 9,852,000	$ 9,845,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	10.75%	10.75%
Margin	3.25%	3.25%
Floor	10.75%	10.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2030	Jan. 01, 2030
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,926,000	4,923,000
Investments at fair value	$ 4,926,000	$ 4,923,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	10.75%	10.75%
Margin	3.25%	3.25%
Floor	10.75%	10.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2030	Jan. 01, 2030
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,926,000	4,923,000
Investments at fair value	$ 4,926,000	$ 4,923,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.25%	12.50%
Margin	4.75%	4.75%
Floor	8.50%	8.50%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,738,000	3,735,000
Investments at fair value	$ 3,738,000	$ 3,735,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.25%	12.50%
Margin	4.75%	4.75%
Floor	8.50%	8.50%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,738,000	3,735,000
Investments at fair value	$ 3,738,000	$ 3,735,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.75%	13.00%
Margin	5.25%	5.25%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,969,000	4,964,000
Investments at fair value	$ 4,969,000	$ 4,964,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.75%	13.00%
Margin	5.25%	5.25%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,947,000	4,937,000
Investments at fair value	4,947,000	4,937,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	231,000	231,000
Investments at fair value	$ 170,000	$ 175,000
Number of Shares (in shares)	5,361,130	5,361,130
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.00%	12.25%
Margin	4.50%	4.50%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.00%	2.00%
Maturity Date	Sep. 01, 2029	Sep. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,924,000	4,920,000
Investments at fair value	$ 4,924,000	$ 4,920,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.00%	12.25%
Margin	4.50%	4.50%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.00%	2.00%
Maturity Date	Sep. 01, 2029	Sep. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,924,000	4,920,000
Investments at fair value	$ 4,924,000	$ 4,920,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.00%	12.25%
Margin	4.50%	4.50%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.00%	2.00%
Maturity Date	Sep. 01, 2029	Sep. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,924,000	4,920,000
Investments at fair value	$ 4,924,000	$ 4,920,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	8.00%	8.00%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,482,000	2,480,000
Investments at fair value	$ 2,482,000	$ 2,480,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	8.00%	8.00%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,482,000	2,480,000
Investments at fair value	$ 2,482,000	$ 2,480,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	8.00%	8.00%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,965,000	4,961,000
Investments at fair value	$ 4,965,000	$ 4,961,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	8.00%	8.00%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,965,000	4,961,000
Investments at fair value	$ 4,965,000	$ 4,961,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	8.00%	8.00%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,716,000	3,714,000
Investments at fair value	$ 3,716,000	$ 3,714,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	8.00%	8.00%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,716,000	3,714,000
Investments at fair value	$ 3,716,000	$ 3,714,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	8.00%	8.00%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,716,000	3,714,000
Investments at fair value	$ 3,716,000	$ 3,714,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	8.00%	8.00%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,716,000	3,714,000
Investments at fair value	$ 3,716,000	$ 3,714,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	1.00%	1.00%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,920,000	4,916,000
Investments at fair value	$ 4,920,000	$ 4,916,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	1.00%	1.00%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 4,250,000	$ 4,250,000
Investments at cost	4,182,000	4,178,000
Investments at fair value	$ 4,182,000	$ 4,178,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	1.00%	1.00%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 4,250,000	$ 4,250,000
Investments at cost	4,182,000	4,178,000
Investments at fair value	$ 4,182,000	$ 4,178,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	1.00%	1.00%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,460,000	2,458,000
Investments at fair value	$ 2,460,000	2,458,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	10.50%
Margin	3.00%
Floor	10.00%
Ceiling	0.00%
ETP	3.00%
Maturity Date	Mar. 01, 2030
Principal Amount	$ 2,507,000
Investments at cost	2,282,000
Investments at fair value	$ 2,282,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	10.50%
Margin	3.00%
Floor	10.00%
Ceiling	0.00%
ETP	3.00%
Maturity Date	Mar. 01, 2030
Principal Amount	$ 2,507,000
Investments at cost	2,482,000
Investments at fair value	$ 2,482,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	10.50%
Margin	3.00%
Floor	10.00%
Ceiling	0.00%
ETP	3.00%
Maturity Date	Mar. 01, 2030
Principal Amount	$ 5,013,000
Investments at cost	4,964,000
Investments at fair value	$ 4,964,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	10.50%
Margin	3.00%
Floor	10.00%
Ceiling	0.00%
ETP	3.00%
Maturity Date	Mar. 01, 2030
Principal Amount	$ 5,013,000
Investments at cost	4,964,000
Investments at fair value	4,964,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | AccuVein Inc [Member] | Common Stock Warrants [Member]
Investments at cost	7,000	7,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	271	271
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerin Medical, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 65,000	$ 65,000
Investments at fair value	$ 1,350,000	$ 1,418,000
Number of Shares (in shares)	1,818,183	1,818,183
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	9.00%
Margin	0.00%
Floor	0.00%
Ceiling	0.00%
ETP	18.00%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 2,500,000
Investments at cost	2,482,000
Investments at fair value	1,816,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	48,000	$ 48,000
Investments at fair value	$ 0	$ 16,000
Number of Shares (in shares)	8,800	8,800
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	9.00%
Margin	0.00%
Floor	0.00%
Ceiling	0.00%
ETP	18.00%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 2,500,000
Investments at cost	2,482,000
Investments at fair value	$ 1,816,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	9.00%
Margin	0.00%
Floor	0.00%
Ceiling	0.00%
ETP	18.00%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 200,000
Investments at cost	192,000
Investments at fair value	140,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate		9.00%
Margin		0.00%
Floor		0.00%
Ceiling		0.00%
ETP		18.00%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 2,500,000
Investments at cost		2,480,000
Investments at fair value		$ 2,085,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate		9.00%
Margin		0.00%
Floor		0.00%
Ceiling		0.00%
ETP		18.00%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 200,000
Investments at cost		190,000
Investments at fair value		$ 160,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index One [Member]
Cash Rate		9.00%
Margin		0.00%
Floor		0.00%
Ceiling		0.00%
ETP		18.00%
Maturity Date		Apr. 01, 2028
Principal Amount		$ 2,500,000
Investments at cost		2,480,000
Investments at fair value		2,085,000
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Canary Medical Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	86,000	86,000
Investments at fair value	$ 1,000	$ 2,000
Number of Shares (in shares)	12,153	12,153
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	$ 0	$ 0
Investments at fair value	$ 2,000	$ 2,000
Number of Shares (in shares)	30,585	30,585
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 162,000	$ 162,000
Investments at fair value	$ 1,000	$ 1,000
Number of Shares (in shares)	4,635,991	4,635,991
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 174,000	$ 174,000
Investments at fair value	$ 471,000	$ 479,000
Number of Shares (in shares)	4,939,813	4,917,794
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CVRx, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 76,000	$ 76,000
Investments at fair value	$ 140,000	$ 160,000
Number of Shares (in shares)	47,410	47,410
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	5.00%	5.00%
Ceiling	0.00%	0.00%
ETP	10.40%	10.40%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 1,778,000	$ 2,000,000
Investments at cost	1,437,000	1,568,000
Investments at fair value	$ 1,437,000	$ 1,568,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	5.00%	5.00%
Ceiling	0.00%	0.00%
ETP	10.40%	10.40%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 2,667,000	$ 3,000,000
Investments at cost	2,277,000	2,529,000
Investments at fair value	$ 2,277,000	$ 2,529,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	11.00%	11.00%
Margin	3.50%	3.50%
Floor	10.50%	10.50%
Ceiling	0.00%	0.00%
ETP	7.78%	7.78%
Maturity Date	Feb. 01, 2028	Feb. 01, 2028
Principal Amount	$ 2,813,000	$ 2,813,000
Investments at cost	2,813,000	2,813,000
Investments at fair value	$ 2,813,000	$ 2,813,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	11.00%	11.00%
Margin	3.50%	3.50%
Floor	10.50%	10.50%
Ceiling	0.00%	0.00%
ETP	7.78%	7.78%
Maturity Date	Feb. 01, 2028	Feb. 01, 2028
Principal Amount	$ 2,813,000	$ 2,813,000
Investments at cost	2,813,000	2,813,000
Investments at fair value	$ 2,813,000	$ 2,813,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Lyrical Foods, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.00%	11.00%
Margin	3.50%	3.50%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jul. 01, 2028	Jul. 01, 2028
Principal Amount	$ 2,679,000	$ 2,679,000
Investments at cost	2,769,000	2,768,000
Investments at fair value	$ 2,418,000	$ 2,405,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.25%	13.50%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 6,204,000	$ 6,042,000
Investments at cost	5,375,000	5,415,000
Investments at fair value	$ 1,258,000	$ 1,271,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	13.25%	13.50%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 2,482,000	$ 3,021,000
Investments at cost	2,687,000	2,707,000
Investments at fair value	$ 630,000	$ 635,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	13.25%	13.50%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 3,102,000	$ 2,417,000
Investments at cost	2,150,000	2,166,000
Investments at fair value	$ 504,000	$ 508,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.25%	13.50%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 3,722,000	$ 3,021,000
Investments at cost	2,687,000	2,707,000
Investments at fair value	$ 630,000	$ 635,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	13.25%	13.50%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 3,102,000	$ 3,625,000
Investments at cost	3,225,000	3,249,000
Investments at fair value	$ 756,000	$ 762,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	13.25%	13.50%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 3,102,000	$ 3,021,000
Investments at cost	2,687,000	2,707,000
Investments at fair value	$ 630,000	$ 635,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	13.25%	13.50%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 6,204,000	$ 6,042,000
Investments at cost	5,375,000	5,415,000
Investments at fair value	$ 1,259,000	$ 1,271,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate	13.25%	13.50%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 3,102,000	$ 3,021,000
Investments at cost	2,686,000	2,707,000
Investments at fair value	$ 629,000	$ 635,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.75%	14.00%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,456,000	2,448,000
Investments at fair value	$ 2,456,000	$ 2,448,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	13.75%	14.00%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jul. 01, 2028	Jul. 01, 2028
Principal Amount	$ 1,875,000	$ 1,875,000
Investments at cost	1,811,000	1,805,000
Investments at fair value	$ 1,811,000	$ 1,805,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12.75%	12.75%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,343,000	2,339,000
Investments at fair value	$ 0	$ 2,267,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12.75%	12.75%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,430,000	2,426,000
Investments at fair value	$ 0	$ 2,352,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12.75%	12.75%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Nov. 01, 2028	Nov. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,421,000	2,417,000
Investments at fair value	$ 0	$ 2,343,000
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.25%	15.25%
Margin	7.75%	7.75%
Floor	11.00%	11.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	May 01, 2027	May 01, 2027
Principal Amount	$ 1,470,000	$ 1,415,000
Investments at cost	1,086,000	1,086,000
Investments at fair value	$ 0	$ 0
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	15.25%	15.25%
Margin	7.75%	7.75%
Floor	11.00%	11.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	May 01, 2027	May 01, 2027
Principal Amount	$ 735,000	$ 708,000
Investments at cost	543,000	543,000
Investments at fair value	$ 0	$ 0
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	15.25%	15.25%
Margin	7.75%	7.75%
Floor	11.00%	11.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	May 01, 2027	May 01, 2027
Principal Amount	$ 735,000	$ 708,000
Investments at cost	543,000	543,000
Investments at fair value	$ 0	$ 0
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.00%	13.00%
Margin	5.50%	5.50%
Floor	10.25%	10.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 10,000,000	$ 10,000,000
Investments at cost	9,968,000	9,977,000
Investments at fair value	$ 9,968,000	$ 9,977,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	13.00%	13.00%
Margin	5.50%	5.50%
Floor	10.25%	10.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 10,000,000	$ 10,000,000
Investments at cost	9,968,000	9,955,000
Investments at fair value	$ 9,968,000	$ 9,955,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	13.00%	13.00%
Margin	5.50%	5.50%
Floor	10.25%	10.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,984,000	4,978,000
Investments at fair value	$ 4,984,000	$ 4,978,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.00%	13.00%
Margin	5.50%	5.50%
Floor	10.25%	10.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,984,000	4,978,000
Investments at fair value	$ 4,984,000	$ 4,978,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 10,000,000	$ 10,000,000
Investments at cost	9,939,000	9,928,000
Investments at fair value	$ 9,939,000	$ 9,928,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,970,000	4,964,000
Investments at fair value	$ 4,970,000	$ 4,964,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.50%	12.50%
Margin	5.00%	5.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,970,000	4,964,000
Investments at fair value	$ 4,970,000	$ 4,964,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.00%	13.25%
Margin	5.50%	5.50%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 7,000,000	$ 7,000,000
Investments at cost	6,962,000	6,954,000
Investments at fair value	$ 6,962,000	$ 6,954,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	13.00%	13.25%
Margin	5.50%	5.50%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 3,500,000	$ 3,500,000
Investments at cost	3,480,000	3,477,000
Investments at fair value	$ 3,480,000	$ 3,477,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	13.00%	13.25%
Margin	5.50%	5.50%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 3,500,000	$ 3,500,000
Investments at cost	3,480,000	3,477,000
Investments at fair value	$ 3,480,000	$ 3,477,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.00%	13.25%
Margin	5.50%	5.50%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 2,750,000	$ 2,750,000
Investments at cost	2,723,000	2,719,000
Investments at fair value	$ 2,723,000	$ 2,719,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.25%	11.125%
Margin	3.75%	3.625%
Floor	11.00%	11.00%
Ceiling	0.00%	0.00%
ETP	3.75%	3.75%
Maturity Date	Jan. 01, 2030	Jan. 01, 2030
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,449,000	2,448,000
Investments at fair value	$ 2,449,000	$ 2,448,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.25%	11.125%
Margin	3.75%	3.625%
Floor	11.00%	11.00%
Ceiling	0.00%	0.00%
ETP	3.75%	3.75%
Maturity Date	Jan. 01, 2030	Jan. 01, 2030
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,475,000	2,474,000
Investments at fair value	$ 2,475,000	$ 2,474,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,939,000	4,934,000
Investments at fair value	$ 4,939,000	$ 4,934,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,939,000	4,934,000
Investments at fair value	$ 4,939,000	$ 4,934,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,939,000	4,934,000
Investments at fair value	$ 4,939,000	$ 4,934,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,939,000	4,934,000
Investments at fair value	$ 4,939,000	$ 4,934,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2027	Oct. 01, 2027
Principal Amount	$ 10,000,000	$ 10,000,000
Investments at cost	9,901,000	9,890,000
Investments at fair value	$ 9,901,000	$ 9,890,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2027	Oct. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,950,000	4,945,000
Investments at fair value	$ 4,950,000	$ 4,945,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2027	Oct. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,950,000	4,945,000
Investments at fair value	$ 4,950,000	$ 4,945,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	11.75%	11.75%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2027	Oct. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,950,000	4,945,000
Investments at fair value	$ 4,950,000	$ 4,945,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Ursa Space Systems Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.00%	12.00%
Margin	4.00%	4.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Nov. 01, 2028	Nov. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,369,000	2,365,000
Investments at fair value	$ 2,369,000	$ 2,365,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Ursa Space Systems Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.00%	12.00%
Margin	4.00%	4.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Nov. 01, 2028	Nov. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,445,000	2,440,000
Investments at fair value	$ 2,445,000	$ 2,440,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.75%	11.75%
Margin	4.00%	4.00%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 4,500,000	$ 4,833,000
Investments at cost	4,464,000	4,791,000
Investments at fair value	$ 4,464,000	$ 4,791,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.75%	11.75%
Margin	4.00%	4.00%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 2,250,000	$ 2,417,000
Investments at cost	2,232,000	2,396,000
Investments at fair value	$ 2,232,000	$ 2,396,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	11.75%	11.75%
Margin	4.00%	4.00%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 2,250,000	$ 2,417,000
Investments at cost	2,232,000	2,396,000
Investments at fair value	$ 2,232,000	$ 2,396,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.00%	11.00%
Margin	3.25%	3.25%
Floor	11.00%	11.00%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,879,000	4,872,000
Investments at fair value	$ 4,879,000	$ 4,872,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.00%	11.00%
Margin	3.25%	3.25%
Floor	11.00%	11.00%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,953,000	4,945,000
Investments at fair value	$ 4,953,000	$ 4,945,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.00%	12.00%
Margin	4.25%	4.25%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,415,000	2,414,000
Investments at fair value	$ 2,415,000	$ 2,414,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.00%	12.00%
Margin	4.25%	4.25%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 3,500,000	$ 3,500,000
Investments at cost	3,492,000	3,492,000
Investments at fair value	$ 3,492,000	$ 3,492,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.00%	12.00%
Margin	4.25%	4.25%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,494,000	2,494,000
Investments at fair value	$ 2,494,000	$ 2,494,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.00%	12.00%
Margin	4.25%	4.25%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 1,500,000	$ 1,500,000
Investments at cost	1,497,000	1,496,000
Investments at fair value	$ 1,497,000	$ 1,496,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	12.00%	12.00%
Margin	4.25%	4.25%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Jul. 01, 2029	Jul. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,985,000	4,984,000
Investments at fair value	$ 4,985,000	$ 4,984,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.00%	14.00%
Margin	5.50%	5.50%
Floor	14.00%	14.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,948,000	4,909,000
Investments at fair value	$ 4,948,000	$ 4,909,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	14.00%	14.00%
Margin	5.50%	5.50%
Floor	14.00%	14.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,474,000	2,472,000
Investments at fair value	$ 2,474,000	$ 2,472,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	14.00%	14.00%
Margin	5.50%	5.50%
Floor	14.00%	14.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,474,000	2,472,000
Investments at fair value	$ 2,474,000	$ 2,472,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14.00%	14.00%
Margin	5.50%	5.50%
Floor	14.00%	14.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,474,000	2,472,000
Investments at fair value	$ 2,474,000	$ 2,472,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	14.00%	14.00%
Margin	5.50%	5.50%
Floor	14.00%	14.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Apr. 01, 2029	Apr. 01, 2029
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,471,000	2,469,000
Investments at fair value	$ 2,471,000	$ 2,469,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	14.00%
Margin	5.50%
Floor	14.00%
Ceiling	0.00%
ETP	3.00%
Maturity Date	Feb. 01, 2030
Principal Amount	$ 2,500,000
Investments at cost	2,465,000
Investments at fair value	$ 2,465,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.00%	12.00%
Margin	4.50%	4.50%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,851,000	4,846,000
Investments at fair value	$ 4,851,000	$ 4,846,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.00%	12.00%
Margin	4.50%	4.50%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,916,000	4,911,000
Investments at fair value	$ 4,916,000	$ 4,911,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.00%	12.00%
Margin	4.50%	4.50%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,916,000	4,911,000
Investments at fair value	$ 4,916,000	$ 4,911,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.00%	14.00%
Margin	6.50%	6.50%
Floor	9.75%	9.75%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 6,804,000	$ 6,804,000
Investments at cost	6,752,000	6,740,000
Investments at fair value	$ 6,440,000	$ 6,362,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	14.00%	14.00%
Margin	6.50%	6.50%
Floor	9.75%	9.75%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 6,280,000	$ 6,280,000
Investments at cost	6,233,000	6,221,000
Investments at fair value	$ 5,943,000	$ 5,872,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	14.00%	14.00%
Margin	6.50%	6.50%
Floor	9.75%	9.75%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 2,617,000	$ 2,617,000
Investments at cost	2,599,000	2,595,000
Investments at fair value	$ 2,479,000	2,449,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | HappyCo, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.50%
Margin	4.00%
Floor	11.00%
Ceiling	0.00%
ETP	2.75%
Maturity Date	Feb. 01, 2030
Principal Amount	$ 3,000,000
Investments at cost	2,913,000
Investments at fair value	$ 2,913,000
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | HappyCo, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.50%
Margin	4.00%
Floor	11.00%
Ceiling	0.00%
ETP	2.75%
Maturity Date	Feb. 01, 2030
Principal Amount	$ 3,000,000
Investments at cost	2,965,000
Investments at fair value	2,965,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Avalo Therapeutics, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	311,000	311,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	117	117
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.00%	12.88%
Margin	4.25%	5.13%
Floor	12.00%
Ceiling	0.00%	13.50%
ETP	4.00%	5.50%
Maturity Date	Mar. 01, 2028	May 01, 2026
Principal Amount	$ 10,000,000	$ 3,333,000
Investments at cost	9,927,000	3,326,000
Investments at fair value	9,927,000	3,326,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	279,000	214,000
Investments at fair value	$ 258,000	$ 270,000
Number of Shares (in shares)	9,775	7,404
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.00%	12.88%
Margin	4.25%	5.13%
Floor	12.00%	9.55%
Ceiling	0.00%	13.50%
ETP	4.00%	5.50%
Maturity Date	Mar. 01, 2028	May 01, 2026
Principal Amount	$ 5,500,000	$ 3,333,000
Investments at cost	5,460,000	3,326,000
Investments at fair value	$ 5,460,000	$ 3,326,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.00%	12.88%
Margin	4.25%	5.13%
Floor	12.00%	9.55%
Ceiling	0.00%	13.50%
ETP	4.00%	5.50%
Maturity Date	Mar. 01, 2028	May 01, 2026
Principal Amount	$ 5,000,000	$ 2,000,000
Investments at cost	4,963,000	1,996,000
Investments at fair value	$ 4,963,000	$ 1,996,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.00%	12.88%
Margin	4.25%	5.13%
Floor	12.00%	9.55%
Ceiling	0.00%	13.50%
ETP	4.00%	5.50%
Maturity Date	Mar. 01, 2028	May 01, 2026
Principal Amount	$ 5,000,000	$ 3,333,000
Investments at cost	4,963,000	3,326,000
Investments at fair value	$ 4,963,000	$ 3,326,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate		12.88%
Margin		5.13%
Floor		9.55%
Ceiling		13.50%
ETP		5.50%
Maturity Date		May 01, 2026
Principal Amount		$ 3,333,000
Investments at cost		3,326,000
Investments at fair value		$ 3,326,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate		12.88%
Margin		5.13%
Floor		9.55%
Ceiling		13.50%
ETP		5.50%
Maturity Date		May 01, 2026
Principal Amount		$ 2,000,000
Investments at cost		1,996,000
Investments at fair value		$ 1,996,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.22%	12.22%
Margin	4.72%	4.72%
Floor	9.75%	9.75%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Nov. 01, 2025	Nov. 01, 2025
Principal Amount	$ 2,917,000	$ 4,167,000
Investments at cost	2,901,000	4,144,000
Investments at fair value	2,901,000	4,144,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	176,000	176,000
Investments at fair value	$ 453,000	$ 129,000
Number of Shares (in shares)	110,402	110,402
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.22%	12.22%
Margin	4.72%	4.72%
Floor	9.75%	9.75%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,981,000	4,982,000
Investments at fair value	4,981,000	4,982,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Imunon, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	65,000	65,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	19,671	19,671
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.25%	12.25%
Margin	4.75%	4.75%
Floor	10.75%	8.50%
Ceiling	0.00%	0.00%
ETP	5.00%	5.50%
Maturity Date	Apr. 01, 2030	May 01, 2027
Principal Amount	$ 5,000,000	$ 6,250,000
Investments at cost	4,983,000	6,220,000
Investments at fair value	4,983,000	6,220,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	118,000	50,000
Investments at fair value	$ 126,000	$ 53,000
Number of Shares (in shares)	105,768	48,076
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.25%	12.25%
Margin	4.75%	4.75%
Floor	10.75%	8.50%
Ceiling	0.00%	0.00%
ETP	5.00%	5.50%
Maturity Date	Apr. 01, 2030	May 01, 2027
Principal Amount	$ 5,000,000	$ 6,250,000
Investments at cost	4,983,000	6,220,000
Investments at fair value	$ 4,983,000	6,220,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	11.25%
Margin	4.75%
Floor	10.75%
Ceiling	0.00%
ETP	5.00%
Maturity Date	Apr. 01, 2030
Principal Amount	$ 5,000,000
Investments at cost	4,983,000
Investments at fair value	$ 4,983,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	11.25%
Margin	3.75%
Floor	10.75%
Ceiling	0.00%
ETP	5.00%
Maturity Date	Apr. 01, 2030
Principal Amount	$ 5,000,000
Investments at cost	4,983,000
Investments at fair value	4,983,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Mustang Bio, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	146,000	146,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	568	16,611
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.75%	12.75%
Margin	5.25%	5.25%
Floor	8.50%	8.50%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Nov. 01, 2026	Nov. 01, 2026
Principal Amount	$ 2,500,000	$ 2,875,000
Investments at cost	2,490,000	2,862,000
Investments at fair value	2,490,000	2,862,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	73,000	73,000
Investments at fair value	$ 66,000	$ 68,000
Number of Shares (in shares)	112,879	112,879
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.75%	12.75%
Margin	5.25%	5.25%
Floor	8.50%	8.50%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Nov. 01, 2026	Nov. 01, 2026
Principal Amount	$ 1,667,000	$ 1,917,000
Investments at cost	1,659,000	1,906,000
Investments at fair value	$ 1,659,000	$ 1,906,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.25%	13.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0.00%	0.00%
ETP	3.75%	3.75%
Maturity Date	Sep. 01, 2026	Sep. 01, 2026
Principal Amount	$ 7,500,000	$ 8,750,000
Investments at cost	7,472,000	8,712,000
Investments at fair value	7,472,000	8,712,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Common Stock Warrants [Member]
Investments at cost	160,000	160,000
Investments at fair value	$ 2,000	$ 14,000
Number of Shares (in shares)	299,848	299,848
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	13.25%	13.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0.00%	0.00%
ETP	3.75%	3.75%
Maturity Date	Sep. 01, 2026	Sep. 01, 2026
Principal Amount	$ 2,813,000	$ 3,281,000
Investments at cost	2,802,000	3,267,000
Investments at fair value	$ 2,802,000	$ 3,267,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	13.25%	13.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0.00%	0.00%
ETP	3.75%	3.75%
Maturity Date	Sep. 01, 2026	Sep. 01, 2026
Principal Amount	$ 2,813,000	$ 3,281,000
Investments at cost	2,802,000	3,267,000
Investments at fair value	$ 2,802,000	$ 3,267,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.86%	12.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	4.30%	4.30%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 3,482,000	$ 3,482,000
Investments at cost	3,426,000	3,418,000
Investments at fair value	2,965,000	3,182,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	278,000	278,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	175,098	175,098
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 312,000	$ 312,000
Investments at fair value	$ 32,000	$ 59,000
Number of Shares (in shares)	709,980	709,980
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.86%	12.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	4.30%	4.30%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 3,482,000	$ 3,482,000
Investments at cost	3,426,000	3,418,000
Investments at fair value	$ 2,965,000	$ 3,182,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.86%	12.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	4.31%	4.31%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 1,741,000	$ 1,741,000
Investments at cost	1,710,000	1,705,000
Investments at fair value	$ 1,480,000	$ 1,588,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.86%	12.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	4.31%	4.31%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 1,741,000	$ 1,741,000
Investments at cost	1,710,000	1,705,000
Investments at fair value	$ 1,480,000	$ 1,588,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	12.86%	12.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	4.31%	4.31%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 1,741,000	$ 1,741,000
Investments at cost	1,708,000	1,704,000
Investments at fair value	$ 1,480,000	$ 1,587,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	12.86%	12.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0.00%	0.00%
ETP	4.31%	4.31%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 1,741,000	$ 1,741,000
Investments at cost	1,708,000	1,704,000
Investments at fair value	$ 1,480,000	$ 1,587,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.25%	13.25%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Jul. 01, 2025	Jul. 01, 2025
Principal Amount	$ 667,000	$ 1,000,000
Investments at cost	652,000	971,000
Investments at fair value	$ 652,000	$ 971,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	13.25%	13.25%
Margin	5.75%	5.75%
Floor	9.00%	9.00%
Ceiling	0.00%	0.00%
ETP	3.00%	3.00%
Maturity Date	Jul. 01, 2025	Jul. 01, 2025
Principal Amount	$ 333,000	$ 500,000
Investments at cost	326,000	486,000
Investments at fair value	$ 326,000	$ 486,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.00%	13.00%
Margin	5.50%	5.50%
Floor	8.75%	8.75%
Ceiling	0.00%	0.00%
ETP	6.00%	6.00%
Maturity Date	Oct. 01, 2025	Oct. 01, 2025
Principal Amount	$ 1,417,000	$ 2,024,000
Investments at cost	1,400,000	1,999,000
Investments at fair value	1,400,000	1,999,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	264,000	264,000
Investments at fair value	$ 23,000	$ 0
Number of Shares (in shares)	318,181	318,181
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	13.00%	13.00%
Margin	5.50%	5.50%
Floor	8.75%	8.75%
Ceiling	0.00%	0.00%
ETP	6.00%	6.00%
Maturity Date	Oct. 01, 2025	Oct. 01, 2025
Principal Amount	$ 708,000	$ 1,012,000
Investments at cost	700,000	1,000,000
Investments at fair value	$ 700,000	$ 1,000,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.25%	12.25%
Margin	4.25%	4.25%
Floor	12.25%	12.25%
Ceiling	0.00%	0.00%
ETP	14.00%	4.00%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,475,000	2,471,000
Investments at fair value	2,356,000	2,471,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	198,000	194,000
Investments at fair value	$ 15,000	$ 167,000
Number of Shares (in shares)	2,266,669	1,600,002
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.25%	12.25%
Margin	4.25%	4.25%
Floor	12.25%	12.25%
Ceiling	0.00%	0.00%
ETP	14.00%	4.00%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,475,000	2,471,000
Investments at fair value	2,356,000	2,471,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Xeris Pharmaceuticals, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	73,000	73,000
Investments at fair value	$ 329,000	$ 91,000
Number of Shares (in shares)	126,000	126,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Long Grove Pharmaceuticals, LLC [Member] | Term Loan, Prime Index, One [Member]
Investments at fair value	$ 9,814,000
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Long Grove Pharmaceuticals, LLC [Member] | Term Loan, SOFR Index, One [Member]
Cash Rate	8.32%
Margin	4.00%
Floor	6.00%
Ceiling	0.00%
ETP	0.00%
Maturity Date	Feb. 27, 2031
Principal Amount	$ 10,037,000
Investments at cost	9,814,000
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Warrant [Member]
Investments at cost	5,290,000	$ 5,149,000
Investments at fair value	6,351,000	6,374,000
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Debt Securities [Member]
Investments at cost	287,787,000
Investments at fair value	284,327,000
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Magnolia Medical Technologies, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	194,000	194,000
Investments at fair value	$ 550,000	$ 368,000
Number of Shares (in shares)	900,043	809,931
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | VERO Biotech LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 379,000	$ 376,000
Investments at fair value	$ 192,000	$ 198,000
Number of Shares (in shares)	3,701	3,701
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Meditrina, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 83,000	$ 83,000
Investments at fair value	$ 33,000	$ 34,000
Number of Shares (in shares)	233,993	233,993
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | MicroTransponder, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 47,000	$ 47,000
Investments at fair value	$ 50,000	$ 66,000
Number of Shares (in shares)	103,172	103,172
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Onkos Surgical, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 192,000	$ 192,000
Investments at fair value	$ 187,000	$ 187,000
Number of Shares (in shares)	443,674	443,674
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Scientia Vascular, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 103,000	$ 103,000
Investments at fair value	$ 426,000	$ 262,000
Number of Shares (in shares)	34,410	34,410
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Sonex Health, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 275,000	$ 275,000
Investments at fair value	$ 260,000	$ 266,000
Number of Shares (in shares)	2,637,133	2,637,133
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Spineology, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 143,000	$ 143,000
Investments at fair value	$ 108,000	$ 108,000
Number of Shares (in shares)	27,139	2,714,033
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Spineology, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 17,000	$ 16,000
Investments at fair value	$ 29,000	$ 28,000
Number of Shares (in shares)	22,551	2,255,155
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member]
Investments at cost	$ 1,146,000	$ 1,146,000
Investments at fair value	100,000	100,000
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Robin Healthcare, Inc. [Member] | Royalty Agreement [Member]
Investments at cost	7,331,000	7,319,000
Investments at fair value	0	0
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member]
Investments at cost		8,918,000
Investments at fair value		10,650,000
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Warrant [Member]
Investments at cost	8,943,000
Investments at fair value	10,643,000
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Debt Securities [Member]
Investments at cost	218,806,000	222,699,000
Investments at fair value	187,791,000	198,350,000
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Havenly, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	3,178,000	3,178,000
Investments at fair value	$ 3,107,000	$ 3,106,000
Number of Shares (in shares)	1,446,429	1,446,429
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Kodiak Robotics, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 273,000	$ 273,000
Investments at fair value	$ 128,000	$ 15,000
Number of Shares (in shares)	639,918	639,918
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Noodle Partners, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 116,000	$ 116,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	84,037	84,037
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 3,000	$ 3,000
Investments at fair value	$ 3,000	$ 3,000
Number of Shares (in shares)	184,646	184,646
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Revinate Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 44,000	$ 44,000
Investments at fair value	$ 88,000	$ 90,000
Number of Shares (in shares)	682,034	682,034
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | SIGNiX, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 225,000	$ 225,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	186,235	186,235
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Mirantis, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 223,000	$ 223,000
Investments at fair value	$ 576,000	$ 585,000
Number of Shares (in shares)	948,275	948,275
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Slingshot Aerospace, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 123,000	$ 123,000
Investments at fair value	$ 51,000	$ 66,000
Number of Shares (in shares)	309,208	309,208
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 188,000	$ 188,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	12,618	12,618
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 9,000	$ 9,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	3,913,723	3,913,723
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Supply Network Visiblity Holdings LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 64,000	$ 65,000
Investments at fair value	$ 73,000	$ 75,000
Number of Shares (in shares)	682	682
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Topia Mobility, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 138,000	$ 138,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	30,496	30,496
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Ursa Space Systems Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 151,000	$ 151,000
Investments at fair value	$ 144,000	$ 148,000
Number of Shares (in shares)	1,075,072	1,075,072
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Viken Detection Corporation [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 120,000	$ 120,000
Investments at fair value	$ 375,000	$ 234,000
Number of Shares (in shares)	345,443	345,443
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | xAd, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 177,000	$ 177,000
Investments at fair value	$ 6,000	$ 6,000
Number of Shares (in shares)	4,343,348	4,343,348
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Optoro, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 182,000	$ 182,000
Investments at fair value	$ 100,000	$ 99,000
Number of Shares (in shares)	11,550	11,550
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Standvast Holdings, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 275,000	$ 275,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	1,225,492	1,225,492
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Axiom Space, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 46,000	$ 46,000
Investments at fair value	$ 24,000	$ 35,000
Number of Shares (in shares)	1,991	1,991
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Unagi, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 32,000	$ 32,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	171,081	171,081
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Intelepeer Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 138,000	$ 138,000
Investments at fair value	$ 3,144,000	$ 3,156,000
Number of Shares (in shares)	2,936,535	2,936,535
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Alula Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 93,000	$ 93,000
Investments at fair value	$ 7,000	$ 7,000
Number of Shares (in shares)	20,000	20,000
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | CAMP NYC, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 36,000	$ 36,000
Investments at fair value	$ 39,000	$ 40,000
Number of Shares (in shares)	112,356	112,356
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Fictiv, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	$ 59,000	$ 59,000
Investments at fair value	$ 73,000	$ 77,000
Number of Shares (in shares)	126,841	126,841
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Clara Foods Co [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 30,000	$ 30,000
Investments at fair value	$ 42,000	$ 43,000
Number of Shares (in shares)	46,745	46,745
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	$ 79,000	$ 79,000
Investments at fair value	$ 4,000	$ 7,000
Number of Shares (in shares)	9,801	9,801
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 454,000	$ 454,000
Investments at fair value	$ 441,000	$ 440,000
Number of Shares (in shares)	45,273	45,273
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Britecore Holdings, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 98,000	$ 98,000
Investments at fair value	$ 238,000	$ 289,000
Number of Shares (in shares)	161,215	161,215
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | MyForest Foods Co [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 29,000	$ 29,000
Investments at fair value	$ 24,000	$ 25,000
Number of Shares (in shares)	250	250
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Crafty Holdings, Inc.[Member] | Common Stock Warrants [Member]
Investments at cost	$ 132,000	$ 132,000
Investments at fair value	$ 132,000	$ 132,000
Number of Shares (in shares)	243,278	243,278
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Primary Kids, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 57,000	$ 57,000
Investments at fair value	$ 369,000	$ 412,000
Number of Shares (in shares)	553,778	553,778
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Quip NYC Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 325,000	$ 325,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	6,191	6,191
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | DropOff, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	$ 455,000	$ 455,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	516,535	516,535
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Updater, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 34,000	$ 34,000
Investments at fair value	$ 26,000	$ 26,000
Number of Shares (in shares)	108,333	108,333
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | CPG Beyond, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 242,000	$ 242,000
Investments at fair value	$ 226,000	$ 231,000
Number of Shares (in shares)	500,000	500,000
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Silk, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 175,000	$ 175,000
Investments at fair value	$ 96,000	$ 119,000
Number of Shares (in shares)	394,110	394,110
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Global Worldwide LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 75,000	$ 75,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	245,810	245,810
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Rocket Lawyer Incorporated [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 92,000	$ 92,000
Investments at fair value	$ 314,000	$ 319,000
Number of Shares (in shares)	261,721	261,721
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | HappyCo, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 26,000
Investments at fair value	$ 23,000
Number of Shares (in shares)	96,228
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Skillshare, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 162,000	$ 162,000
Investments at fair value	$ 597,000	$ 680,000
Number of Shares (in shares)	139,074	139,074
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Liqid, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 364,000	$ 364,000
Investments at fair value	$ 100,000	$ 103,000
Number of Shares (in shares)	344,102	344,102
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Avalanche Technology, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 45,000	$ 45,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	5,938	5,938
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | E La Carte, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 60,000	$ 60,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	147,361	147,361
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Everstream Holdings, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 82,000	$ 82,000
Investments at fair value	$ 26,000	$ 34,000
Number of Shares (in shares)	525,000	525,000
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Lemongrass Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 34,000	$ 34,000
Investments at fair value	$ 47,000	$ 48,000
Number of Shares (in shares)	101,308	101,308
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Debt Securities [Member]
Investments at cost		$ 67,637,000
Investments at fair value		$ 67,052,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Aerofarms, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.25%
Margin		6.75%
Floor		10.00%
Ceiling		0.00%
ETP		4.33%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 3,594,000
Investments at cost		3,564,000
Investments at fair value		$ 3,564,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Aerofarms, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate		14.25%
Margin		6.75%
Floor		10.00%
Ceiling		0.00%
ETP		4.33%
Maturity Date		Dec. 01, 2026
Principal Amount		$ 3,594,000
Investments at cost		3,564,000
Investments at fair value		$ 3,564,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.25%
Margin	6.75%
Floor	10.00%
Ceiling	0.00%
ETP	4.33%
Maturity Date	Dec. 01, 2026
Principal Amount	$ 3,125,000
Investments at cost	3,102,000
Investments at fair value	$ 3,102,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	14.25%
Margin	6.75%
Floor	10.00%
Ceiling	0.00%
ETP	4.33%
Maturity Date	Dec. 01, 2026
Principal Amount	$ 3,125,000
Investments at cost	3,102,000
Investments at fair value	$ 3,102,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.75%	2.75%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,941,000	4,922,000
Investments at fair value	$ 4,528,000	$ 4,792,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.75%	2.75%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,471,000	2,461,000
Investments at fair value	$ 2,264,000	$ 2,396,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.75%	2.75%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,941,000	4,922,000
Investments at fair value	$ 4,528,000	$ 4,792,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.75%	2.75%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,470,000	2,461,000
Investments at fair value	$ 2,264,000	$ 2,396,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	13.00%	13.00%
Margin	5.50%	5.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	2.75%	2.75%
Maturity Date	Dec. 01, 2026	Dec. 01, 2026
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,939,000	4,925,000
Investments at fair value	$ 4,526,000	$ 4,795,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	13.00%	13.00%
Margin	5.50%	5.50%
Floor	11.75%	11.75%
Ceiling	0.00%	0.00%
ETP	2.75%	2.75%
Maturity Date	Dec. 01, 2026	Dec. 01, 2026
Principal Amount	$ 2,500,000	$ 2,500,000
Investments at cost	2,469,000	2,462,000
Investments at fair value	$ 2,263,000	$ 2,397,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,710,000	3,707,000
Investments at fair value	$ 3,710,000	$ 3,707,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,710,000	3,707,000
Investments at fair value	$ 3,710,000	$ 3,707,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 7,500,000	$ 7,500,000
Investments at cost	7,415,000	7,407,000
Investments at fair value	$ 7,415,000	$ 7,407,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,708,000	3,704,000
Investments at fair value	$ 3,708,000	$ 3,704,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	14.25%	14.25%
Margin	6.75%	6.75%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,708,000	3,704,000
Investments at fair value	$ 3,708,000	$ 3,704,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	13.50%	13.50%
Margin	6.00%	6.00%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.00%	2.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 4,500,000	$ 4,500,000
Investments at cost	4,457,000	4,454,000
Investments at fair value	$ 4,457,000	$ 4,454,000
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	13.50%	13.50%
Margin	6.00%	6.00%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	2.00%	2.00%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 2,000,000	$ 2,000,000
Investments at cost	1,981,000	1,980,000
Investments at fair value	$ 1,981,000	$ 1,980,000
Investment, Unaffiliated Issuer [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.00%	12.00%
Margin	4.00%	4.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Feb. 01, 2029	Feb. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,745,000	4,742,000
Investments at fair value	$ 4,745,000	$ 4,742,000
Investment, Unaffiliated Issuer [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.00%	12.00%
Margin	4.00%	4.00%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Feb. 01, 2029	Feb. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,954,000	4,951,000
Investments at fair value	4,954,000	4,951,000
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Warrant [Member]
Investments at cost	713,000	715,000
Investments at fair value	153,000	187,000
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Debt Securities [Member]
Investments at cost	66,823,000
Investments at fair value	64,965,000
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Pivot Bio, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	14,000	14,000
Investments at fair value	$ 10,000	$ 14,000
Number of Shares (in shares)	210,418	210,418
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 81,000	$ 82,000
Investments at fair value	$ 12,000	$ 17,000
Number of Shares (in shares)	400,000	400,000
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 20,000	$ 20,000
Investments at fair value	$ 0	$ 19,000
Number of Shares (in shares)	296	296
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 382,000	$ 382,000
Investments at fair value	$ 9,000	$ 10,000
Number of Shares (in shares)	1,075	1,075
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | LiquiGlide, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 38,000	$ 39,000
Investments at fair value	$ 23,000	$ 25,000
Number of Shares (in shares)	61,359	61,359
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Temperpack Technologies, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 178,000	$ 178,000
Investments at fair value	$ 99,000	$ 102,000
Number of Shares (in shares)	49,693	49,693
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.25%	11.25%
Margin	3.25%	3.25%
Floor	11.25%	11.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2029	Oct. 01, 2029
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,597,000	3,595,000
Investments at fair value	$ 3,597,000	$ 3,595,000
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.25%	11.25%
Margin	3.25%	3.25%
Floor	11.25%	11.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2029	Oct. 01, 2029
Principal Amount	$ 3,750,000	$ 3,750,000
Investments at cost	3,697,000	3,695,000
Investments at fair value	$ 3,697,000	$ 3,695,000
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	11.25%	11.25%
Margin	3.25%	3.25%
Floor	11.25%	11.25%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Oct. 01, 2029	Oct. 01, 2029
Principal Amount	$ 7,500,000	$ 7,500,000
Investments at cost	7,394,000	7,389,000
Investments at fair value	$ 7,394,000	$ 7,389,000
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.25%	11.25%
Margin	3.25%	3.25%
Floor	11.25%	11.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,856,000	4,854,000
Investments at fair value	$ 4,856,000	$ 4,854,000
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.25%	11.25%
Margin	3.25%	3.25%
Floor	11.25%	11.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,956,000	4,954,000
Investments at fair value	$ 4,956,000	$ 4,954,000
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	11.25%	11.25%
Margin	3.25%	3.25%
Floor	11.25%	11.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,956,000	4,954,000
Investments at fair value	$ 4,956,000	$ 4,954,000
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	11.25%	11.25%
Margin	3.25%	3.25%
Floor	11.25%	11.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,956,000	4,954,000
Investments at fair value	$ 4,956,000	$ 4,954,000
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	11.25%	11.25%
Margin	3.25%	3.25%
Floor	11.25%	11.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,956,000	4,954,000
Investments at fair value	4,956,000	4,954,000
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Warrant [Member]
Investments at cost	1,047,000	1,047,000
Investments at fair value	1,456,000	1,066,000
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Debt Securities [Member]
Investments at cost	107,566,000	106,940,000
Investments at fair value	104,815,000	104,189,000
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	167,000	167,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	85,066	85,066
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Elligo Healthcare Research, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 191,000	$ 191,000
Investments at fair value	$ 72,000	$ 92,000
Number of Shares (in shares)	652,250	652,250
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | SafelyYou, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 163,000	$ 163,000
Investments at fair value	$ 144,000	$ 149,000
Number of Shares (in shares)	206,983	150,353
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | GT Medical Technologies, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 83,000	$ 83,000
Investments at fair value	$ 93,000	$ 95,000
Number of Shares (in shares)	195,984	195,984
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 45,000	$ 45,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	451,796	451,796
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	$ 71,000	$ 71,000
Investments at fair value	$ 96,000	$ 15,000
Number of Shares (in shares)	32,244	32,244
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 166,000	$ 166,000
Investments at fair value	$ 346,000	$ 15,000
Number of Shares (in shares)	184,253	184,253
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 101,000	$ 101,000
Investments at fair value	$ 705,000	$ 700,000
Number of Shares (in shares)	82,965	82,965
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 60,000	$ 60,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	7,097,792	7,097,792
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Fictiv, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.00%	10.88%
Margin	3.50%	3.375%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Apr. 01, 2029	Apr. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,709,000	4,706,000
Investments at fair value	$ 4,709,000	$ 4,706,000
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Fictiv, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.00%	10.88%
Margin	3.50%	3.375%
Floor	10.00%	10.00%
Ceiling	0.00%	0.00%
ETP	4.00%	4.00%
Maturity Date	Apr. 01, 2029	Apr. 01, 2029
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,944,000	4,941,000
Investments at fair value	$ 4,944,000	$ 4,941,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.50%	13.50%
Margin	6.00%	6.00%
Floor	9.25%	9.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 1,929,000	$ 1,607,000
Investments at cost	300,000	1,576,000
Investments at fair value	$ 187,000	$ 943,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	13.50%	13.50%
Margin	6.00%	6.00%
Floor	9.25%	9.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 1,607,000	$ 1,607,000
Investments at cost	1,575,000	1,576,000
Investments at fair value	$ 982,000	$ 943,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	13.50%	13.50%
Margin	6.00%	6.00%
Floor	9.25%	9.25%
Ceiling	0.00%	0.00%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 1,607,000	$ 3,214,000
Investments at cost	1,575,000	3,151,000
Investments at fair value	$ 982,000	$ 1,886,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.50%	14.00%
Margin	6.00%	0.00%
Floor	9.25%	0.00%
Ceiling	0.00%	0.00%
ETP	3.50%	50.00%
Maturity Date	Jun. 01, 2026	Mar. 01, 2025
Principal Amount	$ 964,000	$ 300,000
Investments at cost	150,000	300,000
Investments at fair value	$ 93,000	$ 180,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	13.50%	14.00%
Margin	6.00%	0.00%
Floor	9.25%	0.00%
Ceiling	0.00%	0.00%
ETP	3.50%	100.00%
Maturity Date	Jun. 01, 2026	Mar. 01, 2025
Principal Amount	$ 3,214,000	$ 250,000
Investments at cost	3,152,000	250,000
Investments at fair value	$ 1,964,000	$ 150,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Fixed Index One [Member]
Cash Rate	14.00%
Margin	0.00%
Floor	0.00%
Ceiling	0.00%
ETP	50.00%
Maturity Date	Mar. 01, 2025
Principal Amount	$ 300,000
Investments at cost	300,000
Investments at fair value	$ 187,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Fixed Index Two [Member]
Cash Rate	14.00%
Margin	0.00%
Floor	0.00%
Ceiling	0.00%
ETP	100.00%
Maturity Date	Mar. 01, 2025
Principal Amount	$ 250,000
Investments at cost	250,000
Investments at fair value	$ 156,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.50%	11.50%
Margin	3.25%	3.25%
Floor	11.50%	11.50%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,750,000	4,659,000
Investments at fair value	$ 4,750,000	$ 4,659,000
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	11.50%	11.50%
Margin	3.25%	3.25%
Floor	11.50%	11.50%
Ceiling	0.00%	0.00%
ETP	5.00%	5.00%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 5,000,000	$ 5,000,000
Investments at cost	4,918,000	4,910,000
Investments at fair value	4,918,000	$ 4,910,000
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		13.75%
Margin		6.00%
Floor		9.25%
Ceiling		0.00%
ETP		2.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 3,750,000
Investments at cost		3,731,000
Investments at fair value		$ 3,731,000
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate		13.75%
Margin		6.00%
Floor		9.25%
Ceiling		0.00%
ETP		2.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 3,750,000
Investments at cost		3,731,000
Investments at fair value		$ 3,731,000
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate		13.75%
Margin		6.00%
Floor		9.25%
Ceiling		0.00%
ETP		2.50%
Maturity Date		Jun. 01, 2026
Principal Amount		$ 3,750,000
Investments at cost		3,731,000
Investments at fair value		3,731,000
Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	47,948,000	44,780,000
Investments at fair value	14,869,000	31,819,000	$ 13,644,000	$ 14,223,000
Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member]
Investments at cost	23,289,000	21,289,000
Investments at fair value	7,910,000	17,921,000
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member]
Investments at cost	18,779,000	17,611,000
Investments at fair value	1,669,000	7,668,000
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member]
Investments at cost	5,880,000	5,880,000
Investments at fair value	5,290,000	6,230,000
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member]
Investments at fair value	879,000	0	7,799,000	7,993,000
Investment, Affiliated Issuer, Controlled [Member] | Nexii Building Solutions, Inc [Member]
Investments at fair value	8,700,000	8,547,000
Investment, Affiliated Issuer, Controlled [Member] | Swift Health Systems Inc. [Member]
Investments at fair value	0	17,042,000
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investments at fair value	$ 5,290,000	$ 6,230,000	5,845,000	6,230,000
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	10.00%	10.25%
Margin	2.50%	2.50%
Floor	2.50%	2.50%
Ceiling	0.00%	0.00%
ETP	9.14%	9.14%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 1,997,000	$ 1,948,000
Investments at cost	1,986,000	1,925,000
Investments at fair value	$ 0	$ 1,658,000
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	10.00%	10.25%
Margin	2.50%	2.50%
Floor	2.50%	2.50%
Ceiling	0.00%	0.00%
ETP	9.14%	9.14%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 1,997,000	$ 1,948,000
Investments at cost	1,977,000	1,925,000
Investments at fair value	$ 0	$ 1,658,000
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	10.00%	10.25%
Margin	2.50%	2.50%
Floor	2.50%	2.50%
Ceiling	0.00%	0.00%
ETP	9.14%	9.14%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 1,997,000	$ 1,948,000
Investments at cost	1,973,000	1,922,000
Investments at fair value	$ 0	$ 1,654,000
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	10.00%	10.25%
Margin	2.50%	2.50%
Floor	2.50%	2.50%
Ceiling	0.00%	0.00%
ETP	9.14%	9.14%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 1,997,000	$ 1,948,000
Investments at cost	1,973,000	1,922,000
Investments at fair value	0	1,654,000
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Preferred Stock [Member]
Investments at cost	12,012,000	10,012
Investments at fair value	$ 0	$ 10,012
Number of Shares (in shares)	4,233,666	3,588,505
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	10.00%	10.25%
Margin	2.50%	2.50%
Floor	2.50%	2.50%
Ceiling	0.00%	0.00%
ETP	100.00%	100.00%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 323,000	$ 315,000
Investments at cost	323,000	315,000
Investments at fair value	$ 0	$ 271,000
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	10.00%	10.25%
Margin	2.50%	2.50%
Floor	2.50%	2.50%
Ceiling	0.00%	0.00%
ETP	100.00%	100.00%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 160,000	$ 156,000
Investments at cost	160,000	156,000
Investments at fair value	$ 0	$ 135,000
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.00%	12.00%
Margin	3.75%	3.75%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.78%	2.78%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 4,133,000	$ 4,012,000
Investments at cost	4,160,000	4,058,000
Investments at fair value	381,000	0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Common Stock [Member]
Investments at cost	639,000	639,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	2,278,272	2,278,272
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Two [Member]
Cash Rate	12.00%	12.00%
Margin	3.75%	3.75%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	2.78%	2.78%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 2,067,000	$ 2,006,000
Investments at cost	1,989,000	1,989,000
Investments at fair value	$ 182,000	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Three [Member]
Cash Rate	12.00%	12.00%
Margin	3.75%	3.75%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	Aug. 01, 2025	Aug. 01, 2025
Principal Amount	$ 554,000	$ 538,000
Investments at cost	538,000	538,000
Investments at fair value	$ 49,000	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.00%	12.00%
Margin	3.75%	3.75%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	Aug. 01, 2025	Aug. 01, 2025
Principal Amount	$ 548,000	$ 532,000
Investments at cost	532,000	532,000
Investments at fair value	49,000	0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Preferred Stock [Member]
Investments at cost	3,922,000	3,922,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	5,350,142	5,350,142
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	12.00%	12.00%
Margin	3.75%	3.75%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	Aug. 01, 2025	Aug. 01, 2025
Principal Amount	$ 537,000	$ 521,000
Investments at cost	521,000	521,000
Investments at fair value	$ 48,000	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	12.00%	12.00%
Margin	3.75%	3.75%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	Aug. 01, 2025	Aug. 01, 2025
Principal Amount	$ 528,000	$ 513,000
Investments at cost	513,000	513,000
Investments at fair value	$ 47,000	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	12.00%	12.00%
Margin	3.75%	3.75%
Floor	12.00%	12.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	Aug. 01, 2025	Aug. 01, 2025
Principal Amount	$ 520,000	$ 505,000
Investments at cost	505,000	505,000
Investments at fair value	$ 46,000	0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate	12.00%
Margin	3.75%
Floor	12.00%
Ceiling	0.00%
ETP	100.00%
Maturity Date	Aug. 01, 2025
Principal Amount	$ 848,000
Investments at cost	839,000
Investments at fair value	77,000
Investment, Affiliated Issuer, Controlled [Member] | Biotechnology Sector [Member] | HIMV LLC [Member] | Other Investments [Member]
Investments at cost	5,880,000	5,880,000
Investments at fair value	5,290,000	6,230,000
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Common Stock [Member]
Investments at cost	3,297,000	3,297,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	108,320	108,320
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Preferred Stock [Member]
Investments at cost	$ 3,419,000	$ 3,419,000
Investments at fair value	$ 7,910,000	$ 7,909,000
Number of Shares (in shares)	542	542
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Debt Securities [Member]
Cash Rate	10.00%	10.00%
Floor	0.00%	0.00%
Ceiling	0.00%	0.00%
ETP	0.00%	0.00%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 790,000	$ 790,000
Investments at cost	790,000	790,000
Investments at fair value	790,000	638,000
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	27,493,000	27,491,000
Investments at fair value	8,307,000	8,307,000	12,577,000	1,132,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member]
Investments at cost	5,000,000	5,000,000
Investments at fair value	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member]
Investments at cost	127,000	127,000
Investments at fair value	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments [Member]
Investments at cost	22,366,000	22,364,000
Investments at fair value	8,307,000	8,307,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member]
Investments at fair value	8,307,000	8,307,000	12,577,000	1,132,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member]
Investments at fair value	0	0	$ 0	$ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Medical Device Sector [Member] | Aulea Medical, Inc. [Member] | Common Stock [Member]
Investments at cost	0	0
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	660,537	660,537
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, One [Member]
Investments at cost	$ 4,910,000	$ 4,910,000
Investments at fair value	1,825,000	1,825,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Common Stock [Member]
Investments at cost	5,000,000	5,000,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	2,164,502	2,164,502
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Two [Member]
Investments at cost	$ 7,636,000	$ 7,634,000
Investments at fair value	2,832,000	2,832,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Three [Member]
Investments at cost	2,946,000	2,946,000
Investments at fair value	1,095,000	1,095,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Four [Member]
Investments at cost	2,946,000	2,946,000
Investments at fair value	1,095,000	1,095,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Warrant [Member]
Investments at cost	127,000	127,000
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	23,196	23,196
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Five [Member]
Investments at cost	$ 1,964,000	$ 1,964,000
Investments at fair value	730,000	730,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Six [Member]
Investments at cost	1,964,000	1,964,000
Investments at fair value	$ 730,000	$ 730,000

X

- Definition

The ceiling rate of the investment owned.

+ References

No definition available.

+ Details

Name:	hrzn_InvestmentOwnedCeilingRate
Namespace Prefix:	hrzn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The end of term payment rate (ETP) on investment owned.

+ References

No definition available.

+ Details

Name:	hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix:	hrzn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Percentage added to reference rate used to compute variable rate on investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Minimum rate of interest on investment.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentInterestRateFloor
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Rate of interest paid in cash on investment.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Maturity date of investment, in YYYY-MM-DD format.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477439/946-210-55-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-12A(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentMaturityDate
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Cost of the investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477439/946-210-55-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19

+ Details

Name:	us-gaap_InvestmentOwnedAtCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Fair value of investment in security owned.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477439/946-210-55-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-2

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(2)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(2)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of principal of investment owned.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477439/946-210-55-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Number of shares of investment owned.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477439/946-210-55-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

+ Details

Name:	us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_UnrestrictedShortTermInvestmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_RestrictedShortTermInvestmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_USBankMoneyMarketDepositAccountMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_EnergyEfficiencyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_PreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_PreferredStock2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MicroTransponderIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_OnkosSurgicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MMLUSIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CVRXIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_StandvastHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_OneNetworksIncdbaFinexioMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthcareResearchIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_UrsaSpaceSystemsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CraftyHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HappyCoIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LongGrovePharmaceuticalLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanSofrIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_FictivIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AerofarmsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_PivotBioIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_GTMedicalTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HometeamTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquitySecuritiesByIndustryAxis=hrzn_HealthcareInformationAndServicesSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_ParseBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexSixMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: